17.8% fall in gross profit

25/04/19 12:10 augustine - Acorda Therapeutics Inc
For the fiscal year ended 31st Dec 2018, Acorda Therapeutics Inc gross profit reported was $372.123M a fall from $452.573M reported in the 2017 financial year. Gross profit represents the total revenues reported minus the costs incurred in the process of generating the revenues.
Edited (2)
The amount value of account Cash And Cash Equivalents for balance date 31/12/14 changed from 18,000,000 USD to 183,000,000 USD.